Celcuity (CELC) Interest Expenses (2017 - 2026)
Celcuity's (CELC) quarterly Interest Expenses came in at $2.9 million in Q4 2025, down 10.63% YoY from $3.3 million in Q4 2024, and down 98.42% on a QoQ basis from $185.0 million in Q3 2025.
Celcuity (CELC) Interest Expenses (2017 - 2026) Analysis & Trends
Celcuity (CELC) has 9 years of Interest Expenses data on file, last reported at $2.9 million in Q4 2025.
- Quarterly Interest Expenses fell 10.63% year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (up 68.89% YoY) and the FY2025 annual result came in at $468.2 million, up 677.55% from the prior year.
- Interest Expenses retreated to $2.9 million in Q4 2025, from $185.0 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $185.0 million in Q3 2025 to a low of -$129755.0 in Q4 2021.
- A 5-year average of $18.1 million and a median of $7.2 million in 2021 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 2116.91% in 2021, down 480674.07% in 2021.
- Tracing CELC's Interest Expenses over 5 years: stood at -$129755.0 in 2021, then surged by 426.09% to $423119.0 in 2022, then soared by 105.29% to $868610.0 in 2023, then soared by 277.04% to $3.3 million in 2024, then retreated by 10.63% to $2.9 million in 2025.
- The last three Interest Expenses figures came in at $2.9 million (Q4 2025), $185.0 million (Q3 2025), and $17.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 464.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 464.98 Mn |
| Jun 30, 2026 | 464.98 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 185.00 Mn |
| Sep 30, 2025 | 185.00 Mn |
| Jun 30, 2025 | 17.83 Mn |
| Jun 30, 2025 | 17.83 Mn |
| Mar 31, 2025 | 6.95 Mn |
| Mar 31, 2025 | 6.95 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 18.65 Mn |
| Sep 30, 2024 | 18.65 Mn |
| Jun 30, 2024 | 23.46 Mn |
| Jun 30, 2024 | 23.46 Mn |
| Mar 31, 2024 | 39.51 Mn |
| Mar 31, 2024 | 39.51 Mn |
| Dec 31, 2023 | 868,610.00 |
| Dec 31, 2023 | 868,610.00 |